本頁面由Tiger Fintech (Singapore) Pte. Ltd.提供服務

拜瑪林製藥

57.71
+0.96001.69%
成交量:75.14萬
成交額:4,318.84萬
市值:110.81億
市盈率:16.98
高:58.03
開:56.64
低:56.58
收:56.75
52周最高:90.01
52周最低:52.93
股本:1.92億
流通股本:1.78億
量比:0.57
換手率:0.42%
股息:- -
股息率:- -
每股收益(TTM):3.40
每股收益(LYR):2.25
淨資產收益率:11.62%
總資產收益率:7.50%
市淨率:1.84
市盈率(LYR):25.69

資料載入中...

2024/05/14

重要事件披露

Form 8-K - Current report
2024/05/10

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/05/09

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/05/03

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/05/02

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/04/26

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/04/24

重要事件披露

Form 8-K - Current report
2024/04/23

重要事件披露

Form 8-K - Current report
2024/04/12

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/04/11

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/04/11

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/03/28

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/03/07

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/03/06

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/03/06

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/03/06

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/02/27

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/02/26

年度報告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2024/02/22

重要事件披露

Form 8-K - Current report
2024/02/13

超過5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]